| Science 1996 Eliot Marshall |
| Title | Subject | Authors |
|---|
| Academy's about-face on forensic DNA.(National Research Council report on DNA fingerprinting) | Science and technology | Eliot Marshall |
| Appropriators bullish on biomedicine. (proposed 1997 National Institutes of Health budget) | Science and technology | Eliot Marshall |
| Clinical promise, ethical quandary. (transplantation of umbilical cord blood)(includes article about private cord blood banks) | Science and technology | Eliot Marshall |
| Congress: biomedical research wins big.(1997 appropriations) | Science and technology | Eliot Marshall, Andrew Lawler |
| Critics say Laskers omitted NO pioneer.(1996 Albert Lasker Award, honoring discoverers of medical significance of nitric oxide, left out Salvador Moncada) | Science and technology | Eliot Marshall |
| Despite anxiety, NIH begins merging neuroscience panels.(National Institutes of Health) | Science and technology | Eliot Marshall |
| Disputed results now just a footnote. (immunology; networks of antibodies)(includes related information on survey of immunologists) | Science and technology | Eliot Marshall |
| Donna Shalala: 'leaving footprints' at HHS. (secretary of Health and Human Services)(Interview) | Science and technology | Eliot Marshall |
| Fraud strikes top genome lab.(researcher fakes data at lab headed by Francis Collins)(includes related article on how the fraud affected other research) | Science and technology | Eliot Marshall |
| Funding crisis grips genome research. (Canada) | Science and technology | Eliot Marshall |
| Gallo's institute at the last hurdle.(Robert Gallo; Institute of Human Virology) | Science and technology | Eliot Marshall |
| Genome researchers take the pledge: data sharing. | Science and technology | Eliot Marshall |
| Heavy hitters anchor the AAAS lineup at annual meeting.(American Association for the Advancement of Science) | Science and technology | Eliot Marshall, Jeffrey Mervis, Andrew Lawler |
| Hot property: biologists who compute. (corporate demand for bioinformatics experts)(includes related article on depletion of university staffs) | Science and technology | Eliot Marshall |
| Imanishi-Kari ruling slams ORI. (Office of Research Integrity's investigation of charges of scientific misconduct against immunologist Thereza Imanishi-Kari) | Science and technology | Eliot Marshall, Jocelyn Kaiser |
| Klausner's unconventional 'field station' in Seattle. (National Cancer Institute Chief Richard Klausner) | Science and technology | Eliot Marshall |
| NCI cuts contracts to fund more grants.(National Cancer Institute) | Science and technology | Eliot Marshall |
| New NIMH director offers institutional stimulant.(Steven Hyman; National Institute of Mental Health) | Science and technology | Eliot Marshall |
| New York courts seek 'neutral' experts. | Science and technology | Eliot Marshall |
| New Zealand's leap into gene therapy. (genetic therapy clinical trial conducted in New Zealand on two American children with Canavan disease) | Science and technology | Eliot Marshall |
| NIH Clinical Center gets a boost.(National Institutes of Health) | Science and technology | Eliot Marshall |
| NIH launches the final push to sequence the genome.(National Institutes of Health; Human Genome Project) | Science and technology | Eliot Marshall, Elizabeth Pennisi |
| NIH panel urges overhaul of the rating system for grants. (National Institutes of Health internal panel recommends changes in peer review process) | Science and technology | Eliot Marshall |
| NIH up, for now; fusion down. (National Institutes of Health)(science spending in 1997 federal budget) | Science and technology | Eliot Marshall, Andrew Lawler |
| Patent office faces 90-year backlog. (patent applications for DNA sequences) | Science and technology | Eliot Marshall |
| Policy on DNA research troubles tissue bankers. (Centers for Disease Control and Prevention develops ethical standards for genetic research on archived blood and tissue samples)(News & Comment) | Science and technology | Eliot Marshall |
| Rifkin's latest target: genetic testing.(activist Jeremy Rifkin) | Science and technology | Eliot Marshall |
| Serious setback for Patarroyo vaccine.(malaria vaccine developed by Manuel Patarroyo) | Science and technology | Eliot Marshall |
| The genome program's conscience: a research program on the ethical, legal, and social implications of genome studies, launched as an "afterthought," is now the world's biggest bioethics program. (includes related article on genetic screening for cystic fibrosis) | Science and technology | Eliot Marshall |
| The human gene hunt scales up. ('Cancer Genome Anatomy Project') | Science and technology | Eliot Marshall |
| The Klausner revolution.(National Cancer Institute under Richard Klausner) | Science and technology | Eliot Marshall |
| Trial set to focus on peer review. (Cistron Biotechnology sues Immunex Corp in patent case) | Science and technology | Eliot Marshall |
| UCSF, Stanford hospitals to merge.(University of California-San Francisco) | Science and technology | Eliot Marshall |
| Varmus proposes to scrap the RAC.(National Institutes of Health director Harold Varmus; Recombinant DNA Advisory Committee) | Science and technology | Eliot Marshall |
| When federal science stopped.(how the federal shutdown affected government science programs)(includes information on 5.7% increase in National Institutes of Health budget for FY 1996) | Science and technology | Eliot Marshall, Jeffrey Mervis |
| Whose genome is it, anyway?(sources for genome sequencing) | Science and technology | Eliot Marshall |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
